APTO News

Latest breaking news and updates for APTO stock.

Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor

Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor

3 days ago

Read more globenewswire

Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy

• Safety Review Committee endorses escalation to 160 mg TUS dosing; no dose-limiting toxicities to date

Could the positive safety committee endorsement trigger short‑term trading activity or short‑covering dynamics in the market? What is the anticipated impact on the company's valuation multiples (e.g., EV/EBITDA, price‑to‑sales) given this trial progression? How might the safety profile of the 160 mg dose affect future dose‑selection decisions for later‑stage trials and overall trial design?

Trials

19 days ago

Read more globenewswire